Autonomix Medical (AMIX) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 10, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about AMIX filings

Are insiders buying or selling Autonomix Medical, Inc. Common Stock (AMIX) stock?

Neither. Autonomix Medical, Inc. Common Stock (AMIX) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AMIX recently?

None. No member of Congress disclosed a AMIX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AMIX smart-money data?

This summary uses filings available on Nov 10, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

Questions about AMIX filings

Are insiders buying or selling Autonomix Medical, Inc. Common Stock (AMIX) stock?

Neither. Autonomix Medical, Inc. Common Stock (AMIX) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AMIX recently?

None. No member of Congress disclosed a AMIX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AMIX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 12, 2026

Earnings came in 21.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 12, 2026

Period ending

Jun 30, 2026

Earnings per share

-$5.02+21.62% beat

-$6.41 expected

Revenue

$0.00

SEC filing

Next report

Estimated report: Nov 11, 2026, tomorrow

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 12, 2026	-$5.02est. -$6.41	+21.62%beat	$0.00SEC filing	No year-ago quarter
Mar 31, 2026Reported Jun 4, 2026	-$0.23est. -$5.46	+95.72%beat	$0.00 · FYSEC filing	No year-ago quarter
Dec 31, 2025Reported Feb 11, 2026	-$7.56est. -$9.66	+21.74%beat	$0.00SEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$28.98est. -$31.50	+8.00%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 13, 2025	-$22.47est. -$20.58	-9.18%miss	$0.00SEC filing	No year-ago quarter
Mar 31, 2025Reported May 29, 2025	-$0.74est. -$1.24	+40.32%beat	$0.00 · FYSEC filing	No year-ago quarter
Dec 31, 2024Reported Feb 13, 2025	-$30.66est. -$50.40	+39.17%beat	$0.00SEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 8, 2024	Not on file	No estimate	$0.00SEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $2.08
High: $2.15
Low: $1.81
Prev close: $2.04
52-wk high: $32.55
52-wk low: $1.46
Mkt cap: $3.0M
ROE: -316.0%
Beta: -0.69
P/B: 0.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3M

Valuation

P/B0.94

Quality

Operating margin0.0%
ROE-316.0%
ROA-157.8%

Growth

Beta-0.69

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

7oversold

20D volatility

68%annualized

52-week range

$1.81

$1.46$32.55

20D support

$1.81recent floor

20D resistance

$3.73recent ceiling

Returns

5D -25.2%20D -52.1%60D -85.1%

Price vs moving averages

SMA20 -33.4%SMA50 -52.7%SMA200 -73.3%

Volume pace

0.25xvs prior 20D

Smart money at a glance

Filings to Nov 10, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about AMIX filings

Are insiders buying or selling Autonomix Medical, Inc. Common Stock (AMIX) stock?

Neither. Autonomix Medical, Inc. Common Stock (AMIX) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AMIX recently?

None. No member of Congress disclosed a AMIX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AMIX smart-money data?

No recent filings found.

Questions about AMIX filings

Are insiders buying or selling Autonomix Medical, Inc. Common Stock (AMIX) stock?

Neither. Autonomix Medical, Inc. Common Stock (AMIX) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AMIX recently?

None. No member of Congress disclosed a AMIX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AMIX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 12, 2026

Earnings came in 21.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 12, 2026

Period ending

Jun 30, 2026

Earnings per share

-$5.02+21.62% beat

-$6.41 expected

Revenue

$0.00

SEC filing

Next report

Estimated report: Nov 11, 2026, tomorrow

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 12, 2026	-$5.02est. -$6.41	+21.62%beat	$0.00SEC filing	No year-ago quarter
Mar 31, 2026Reported Jun 4, 2026	-$0.23est. -$5.46	+95.72%beat	$0.00 · FYSEC filing	No year-ago quarter
Dec 31, 2025Reported Feb 11, 2026	-$7.56est. -$9.66	+21.74%beat	$0.00SEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$28.98est. -$31.50	+8.00%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 13, 2025	-$22.47est. -$20.58	-9.18%miss	$0.00SEC filing	No year-ago quarter
Mar 31, 2025Reported May 29, 2025	-$0.74est. -$1.24	+40.32%beat	$0.00 · FYSEC filing	No year-ago quarter
Dec 31, 2024Reported Feb 13, 2025	-$30.66est. -$50.40	+39.17%beat	$0.00SEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 8, 2024	Not on file	No estimate	$0.00SEC filing	No year-ago quarter

Open: $2.08
High: $2.15
Low: $1.81
Prev close: $2.04
52-wk high: $32.55
52-wk low: $1.46
Mkt cap: $3.0M
ROE: -316.0%
Beta: -0.69
P/B: 0.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3M

Valuation

P/B0.94

Quality

Operating margin0.0%
ROE-316.0%
ROA-157.8%

Growth

Beta-0.69

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

7oversold

20D volatility

68%annualized

52-week range

$1.81

$1.46$32.55

20D support

$1.81recent floor

20D resistance

$3.73recent ceiling

Returns

5D -25.2%20D -52.1%60D -85.1%

Price vs moving averages

SMA20 -33.4%SMA50 -52.7%SMA200 -73.3%

Volume pace

0.25xvs prior 20D

Autonomix Medical, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about AMIX filings

Questions about AMIX filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 21.6% above what analysts expected.

Estimated report: Nov 11, 2026, tomorrow

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Autonomix Medical, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about AMIX filings

Questions about AMIX filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 21.6% above what analysts expected.

Estimated report: Nov 11, 2026, tomorrow

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Autonomix Medical, Inc. Common Stock

Overview

Questions about AMIX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Autonomix Medical, Inc. Common Stock

Overview

Questions about AMIX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.